Showing 5,481 - 5,500 results of 15,266 for search '(( significantly ((we decrease) OR (greater decrease)) ) OR ( significantly increased decrease ))', query time: 0.50s Refine Results
  1. 5481

    Improved Accuracy and Reliability in Untargeted Analysis with LC-ESI-QTOF/MS<sup>1</sup> by Ensemble Averaging by Guillaume Laurent Erny (21000926)

    Published 2025
    “…It was proved that ensemble averaging allows an increase in the S/N up to a factor of 10, and the relative standard deviation of the accurate masses and retention time decreased by a factor of 10. …”
  2. 5482

    Improved Accuracy and Reliability in Untargeted Analysis with LC-ESI-QTOF/MS<sup>1</sup> by Ensemble Averaging by Guillaume Laurent Erny (21000926)

    Published 2025
    “…It was proved that ensemble averaging allows an increase in the S/N up to a factor of 10, and the relative standard deviation of the accurate masses and retention time decreased by a factor of 10. …”
  3. 5483

    Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

    Published 2025
    “…After intervention there was a significant decrease in the FR group (mean at V1: 0.249 ± 0.094, mean at V5: 0.130 ± 0.101, difference: −0.119 ± 0.097, p < 0.001) and a significant increase in the SM group (mean at V1: 0.156 ± 0.113, mean at V5: 0.287 ± 0.107, difference: 0.131 ± 0.066, p < 0.001). …”
  4. 5484

    Cyclization Decoded: Engineering Amylomaltase for Efficient α‑Glucan Transformations by Han Liu (288039)

    Published 2025
    “…Furthermore, we identify that postglycosylation noncovalent polysaccharide chain transfer emerges as the decisive factor in cyclization, particularly for AM–degree of polymerization (DP) greater than 30 substrate complexes, where this noncovalent step (≥13.6 kcal/mol) dictates the rate of CA production. 57 variants with enhanced activity (up to a 2.3-fold increase) were engineered in our biochemical experiments by strategically modulating the chain transfer step. …”
  5. 5485
  6. 5486
  7. 5487
  8. 5488
  9. 5489
  10. 5490
  11. 5491
  12. 5492

    Flowchart of study population. by Yan Zeng (120271)

    Published 2025
    “…</p><p>Conclusions</p><p>In MM patients in ICU, both minimum and maximum PLT were significantly associated with an increased risk of in-hospital mortality in critical ill patients with MM. …”
  13. 5493

    Primer sequences. by Ceyan Kuang (8554557)

    Published 2025
    “…Microinjection of HL-IR double-stranded RNA (dsRNA) showed that reduced transcript levels led to significant decreases in the tick repellency rate from cinnamaldehyde and the EAG response of Haller’s organ. …”
  14. 5494

    Current vaccine delivery model. by Pamela Bakkabulindi (12914980)

    Published 2024
    “…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”
  15. 5495

    Vaccine stock status, Gomba district, Uganda. by Pamela Bakkabulindi (12914980)

    Published 2024
    “…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”
  16. 5496

    Informed push model. by Pamela Bakkabulindi (12914980)

    Published 2024
    “…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”
  17. 5497

    Source of funds for vaccine pick-up at baseline. by Pamela Bakkabulindi (12914980)

    Published 2024
    “…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”
  18. 5498

    S1 Dataset - by Pamela Bakkabulindi (12914980)

    Published 2024
    “…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”
  19. 5499

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of <b>NP3-742</b>, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.…”
  20. 5500

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of <b>NP3-742</b>, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.…”